Onconova Therapeutics (ONTX) Reports Q2 Loss of $1.96/Share
Tweet
Share
E-mailGet Alerts ONTX Hot Sheet
Join SI Premium – FREE
Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($1.96), versus ($4.13) reported last year. Revenue for the quarter came in at $2.25 million, versus $123 thousand reported last year.
For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
